Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valvular Atrial Fibrillation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00262600
What this trial is testing

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Who this might be right for
Atrial FibrillationStroke
Boehringer Ingelheim 18,113
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Not applicableStudy completedNCT03359876
What this trial is testing

Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction

Who this might be right for
Atrial Fibrillation
Bayer 16,000
Not applicableNot Yet RecruitingNCT07616414
What this trial is testing

Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)ThromboembolismCardiac Implantable Electronic Device+2 more
Fu Wai Hospital, Beijing, China 424
Not applicableStudy completedNCT02362659
What this trial is testing

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry

Who this might be right for
Non-valvular Atrial Fibrillation
Icahn School of Medicine at Mount Sinai 514
Testing effectiveness (Phase 2)Study completedNCT00973245
What this trial is testing

BAY59-7939 in Atrial Fibrillation Once Daily (OD)

Who this might be right for
Atrial Fibrillation
Bayer 102
Not applicableUnknownNCT04550637
What this trial is testing

A Multi-center Study of Apixaban(APPROACH)

Who this might be right for
Evaluate the Safety and Efficacy of Apixaban
Shanghai Zhongshan Hospital 200
Not applicableStudy completedNCT03847181
What this trial is testing

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Who this might be right for
Atrial Fibrillation
Bayer 45,164
Not applicableStudy completedNCT03570047
What this trial is testing

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 73,989
Testing effectiveness (Phase 2)Study completedNCT00829933
What this trial is testing

Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Co., Ltd. 536
Not applicableStudy completedNCT02631057
What this trial is testing

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,313
Not applicableStudy completedNCT06606275
What this trial is testing

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis

Who this might be right for
End-Stage Kidney Disease (ESKD)Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)
Abu Dhabi Health Services Company 67
Not applicableStudy completedNCT02754154
What this trial is testing

Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 321,182
Not applicableLooking for participantsNCT07042529
What this trial is testing

Optimized Expansion of the Implanted Transcatheter Aortic Valve

Who this might be right for
Aortic Stenosis DiseaseValvular Heart Disease
Ole De Backer 1,010
Not applicableStudy completedNCT04519944
What this trial is testing

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Who this might be right for
Non-valvular Atrial Fibrillation
Daiichi Sankyo 666
Not applicableWithdrawnNCT04684212
What this trial is testing

Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF

Who this might be right for
Atrial FibrillationLeft Atrial Appendage ThrombosisCVA
Brian O'Neill MD
Post-approval studies (Phase 4)UnknownNCT03088072
What this trial is testing

A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

Who this might be right for
Non-Valvular Atrial FibrillationLeft Atrial Appendage Closure
Scripps Health 75
Not applicableLooking for participantsNCT05204212
What this trial is testing

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent
Prof. Dr. med. Ingo Eitel 430
Not applicableStudy completedNCT02559232
What this trial is testing

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 247
Testing effectiveness (Phase 2)Study completedNCT00645853
What this trial is testing

Long-term Safety in Atrial Fibrillation Patients

Who this might be right for
Persistent or Permanent Nonvalvular Atrial Fibrillation
AstraZeneca 523
Next Page